THE ACTIVE
HairAGE Vitae®
81%
Users reported their hair fall was under control.
97%
Users felt their hair texture definitely improved after use.
90%
Men observed new growth in clinical hair card tests.
100%
Women reported improvement in hair loss symptoms.
HOW IT WORKS


THE EVIDENCE
Proof behind the claims
A 12-week double-blind, randomized, clinical trial investigated the efficacy and safety of a topical application of Ageratum conyzoides in males and females over 18-years of age
| Measurement | Clinical Result (12-Week Topical Study) |
|---|---|
| Hair Density | Statistically significant increase from baseline as early as 8 weeks. |
| Hair Loss Ratio (HLR) | Significant reduction in HLR, indicating active regrowth in thinning areas. |
| Temporal Recession | Clinical reduction in men's recession distance from 8.6cm to 7.5cm (Pilot Study) |
PROOF OF CLAIMS
Basis: In-Vivo consumer feedback study done with 200+ participants to study the hair growth patterns and hair fall reduction after regular use for 8 weeks under dermatological supervision (July 2025).
Clayton P, et al. Ageratum Conyzoides L. Extract Inhibits 5$\alpha$-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells. Journal of Cosmetology & Trichology. 2021; 7(1)
Clayton P, et al. Efficacy of a Topical Application of Ageratum Conyzoides on increasing Hair Growth in Males and Females: A Randomized Double-Blind Placebo-Controlled Study. Trichol Cosmetol Open J. 2022; 5(1): 10-15.


